Please use this identifier to cite or link to this item: http://elar.urfu.ru/handle/10995/112273
Title: Modified Desolvation Method Enables Simple One-Step Synthesis of Gelatin Nanoparticles from Different Gelatin Types with Any Bloom Values
Authors: Khramtsov, P.
Burdina, O.
Lazarev, S.
Novokshonova, A.
Bochkova, M.
Timganova, V.
Kiselkov, D.
Minin, A.
Zamorina, S.
Rayev, M.
Issue Date: 2021
Publisher: MDPI
MDPI AG
Citation: Modified Desolvation Method Enables Simple One-Step Synthesis of Gelatin Nanoparticles from Different Gelatin Types with Any Bloom Values / P. Khramtsov, O. Burdina, S. Lazarev et al. // Pharmaceutics. — 2021. — Vol. 13. — Iss. 10. — 1537.
Abstract: Gelatin nanoparticles found numerous applications in drug delivery, bioimaging, immunotherapy, and vaccine development as well as in biotechnology and food science. Synthesis of gelatin nanoparticles is usually made by a two-step desolvation method, which, despite providing stable and homogeneous nanoparticles, has many limitations, namely complex procedure, low yields, and poor reproducibility of the first desolvation step. Herein, we present a modified one-step desolvation method, which enables the quick, simple, and reproducible synthesis of gelatin nanoparticles. Using the proposed method one can prepare gelatin nanoparticles from any type of gelatin with any bloom number, even with the lowest ones, which remains unattainable for the traditional two-step technique. The method relies on quick one-time addition of poor solvent (preferably isopropyl alcohol) to gelatin solution in the absence of stirring. We applied the modified desolvation method to synthesize nanoparticles from porcine, bovine, and fish gelatin with bloom values from 62 to 225 on the hundreds-of-milligram scale. Synthesized nanoparticles had average diameters between 130 and 190 nm and narrow size distribution. Yields of synthesis were 62–82% and can be further increased. Gelatin nanoparticles have good colloidal stability and withstand autoclaving. Moreover, they were non-toxic to human immune cells. © 2021 by the authors. Licensee MDPI, Basel, Switzerland.
Keywords: COACERVATION
DRUG DELIVERY
ENCAPSULATION
MANUFACTURING
NANOCARRIERS
NANOPRECIPITATION
YIELD
URI: http://elar.urfu.ru/handle/10995/112273
Access: info:eu-repo/semantics/openAccess
SCOPUS ID: 85116390561
WOS ID: 000717015600001
PURE ID: 23814874
ISSN: 1999-4923
DOI: 10.3390/pharmaceutics13101537
metadata.dc.description.sponsorship: Funding: The reported study was funded by RFBR and Kaliningrad Oblast according to the research project № 19-415-393005 (preparation of fluorescence gelatin nanoparticles and study of their fluorescent properties), by RFBR research project 19-015-00408 (preparation of gelatin nanoparticles by the desolvation method), and by Ministry of Science and Higher Education of the Russian Federation within the framework of the Russian State Assignment under contract No. AAAA-А19-119112290010-7 (assessment of nanoparticles cytotoxicity).
Appears in Collections:Научные публикации ученых УрФУ, проиндексированные в SCOPUS и WoS CC

Files in This Item:
File Description SizeFormat 
2-s2.0-85116390561.pdf6,42 MBAdobe PDFView/Open


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.